167 related articles for article (PubMed ID: 25815753)
1. MUC1 selectively targets human pancreatic cancer in orthotopic nude mouse models.
Park JY; Hiroshima Y; Lee JY; Maawy AA; Hoffman RM; Bouvet M
PLoS One; 2015; 10(3):e0122100. PubMed ID: 25815753
[TBL] [Abstract][Full Text] [Related]
2. Targeting the insulin growth factor-1 receptor with fluorescent antibodies enables high resolution imaging of human pancreatic cancer in orthotopic mouse models.
Park JY; Lee JY; Zhang Y; Hoffman RM; Bouvet M
Oncotarget; 2016 Apr; 7(14):18262-8. PubMed ID: 26919100
[TBL] [Abstract][Full Text] [Related]
3. Tumor-Specific Labeling of Pancreatic Cancer Using a Humanized Anti-CEA Antibody Conjugated to a Near-Infrared Fluorophore.
Lwin TM; Murakami T; Miyake K; Yazaki PJ; Shivley JE; Hoffman RM; Bouvet M
Ann Surg Oncol; 2018 Apr; 25(4):1079-1085. PubMed ID: 29372363
[TBL] [Abstract][Full Text] [Related]
4. MUC-1 aptamer targeted superparamagnetic iron oxide nanoparticles for magnetic resonance imaging of pancreatic cancer in vivo and in vitro experiment.
Zou Q; Zhang CJ; Yan YZ; Min ZJ; Li CS
J Cell Biochem; 2019 Nov; 120(11):18650-18658. PubMed ID: 31338877
[TBL] [Abstract][Full Text] [Related]
5. Comparison of a chimeric anti-carcinoembryonic antigen antibody conjugated with visible or near-infrared fluorescent dyes for imaging pancreatic cancer in orthotopic nude mouse models.
Maawy AA; Hiroshima Y; Kaushal S; Luiken GA; Hoffman RM; Bouvet M
J Biomed Opt; 2013 Dec; 18(12):126016. PubMed ID: 24356647
[TBL] [Abstract][Full Text] [Related]
6. Radioimmunoscintigraphy of pancreatic cancer in tumor-bearing athymic nude mice using (99m)technetium-labeled anti-KL-6/MUC1 antibody.
Matsumura K; Niki I; Tian H; Takuma M; Hongo N; Matsumoto S; Mori H
Radiat Med; 2008 Apr; 26(3):133-9. PubMed ID: 18683568
[TBL] [Abstract][Full Text] [Related]
7. Fluorescent-Antibody Targeting of Insulin-Like Growth Factor-1 Receptor Visualizes Metastatic Human Colon Cancer in Orthotopic Mouse Models.
Park JY; Murakami T; Lee JY; Zhang Y; Hoffman RM; Bouvet M
PLoS One; 2016; 11(1):e0146504. PubMed ID: 26731105
[TBL] [Abstract][Full Text] [Related]
8. Near-infrared-conjugated humanized anti-carcinoembryonic antigen antibody targets colon cancer in an orthotopic nude-mouse model.
DeLong JC; Murakami T; Yazaki PJ; Hoffman RM; Bouvet M
J Surg Res; 2017 Oct; 218():139-143. PubMed ID: 28985840
[TBL] [Abstract][Full Text] [Related]
9. Near infra-red photoimmunotherapy with anti-CEA-IR700 results in extensive tumor lysis and a significant decrease in tumor burden in orthotopic mouse models of pancreatic cancer.
Maawy AA; Hiroshima Y; Zhang Y; Heim R; Makings L; Garcia-Guzman M; Luiken GA; Kobayashi H; Hoffman RM; Bouvet M
PLoS One; 2015; 10(3):e0121989. PubMed ID: 25799218
[TBL] [Abstract][Full Text] [Related]
10. A Novel Monoclonal Antibody Targets Mucin1 and Attenuates Growth in Pancreatic Cancer Model.
Wu G; Maharjan S; Kim D; Kim JN; Park BK; Koh H; Moon K; Lee Y; Kwon HJ
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29987260
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a novel monoclonal antibody against tumor-associated MUC1 for diagnosis and prognosis of breast cancer.
Stergiou N; Nagel J; Pektor S; Heimes AS; Jäkel J; Brenner W; Schmidt M; Miederer M; Kunz H; Roesch F; Schmitt E
Int J Med Sci; 2019; 16(9):1188-1198. PubMed ID: 31588183
[TBL] [Abstract][Full Text] [Related]
12. Fluorescence-guided surgery with a fluorophore-conjugated antibody to carcinoembryonic antigen (CEA), that highlights the tumor, improves surgical resection and increases survival in orthotopic mouse models of human pancreatic cancer.
Metildi CA; Kaushal S; Pu M; Messer KA; Luiken GA; Moossa AR; Hoffman RM; Bouvet M
Ann Surg Oncol; 2014 Apr; 21(4):1405-11. PubMed ID: 24499827
[TBL] [Abstract][Full Text] [Related]
13. The use of a novel MUC1 antibody to identify cancer stem cells and circulating MUC1 in mice and patients with pancreatic cancer.
Curry JM; Thompson KJ; Rao SG; Besmer DM; Murphy AM; Grdzelishvili VZ; Ahrens WA; McKillop IH; Sindram D; Iannitti DA; Martinie JB; Mukherjee P
J Surg Oncol; 2013 Jun; 107(7):713-22. PubMed ID: 23335066
[TBL] [Abstract][Full Text] [Related]
14. Comparative study on the antitumor effects of gemcitabine polybutylcyanoacrylate nanoparticles coupled with anti-human MUC1 and CA199 monoclonal antibodies on pancreatic cancer in vitro and in vivo.
Zhang L; Hou Y; Li C; Liu H; Wang Y
Arab J Gastroenterol; 2022 Nov; 23(4):263-269. PubMed ID: 35922259
[TBL] [Abstract][Full Text] [Related]
15. In vivo anti-MUC1
Pichinuk E; Chalik M; Benhar I; Ginat-Koton R; Ziv R; Smorodinsky NI; Haran G; Garbar C; Bensussan A; Meeker A; Guillaume T; Rubinstein DB; Wreschner DH
Cancer Immunol Immunother; 2020 Jul; 69(7):1337-1352. PubMed ID: 32219500
[TBL] [Abstract][Full Text] [Related]
16. Specific tumor labeling enhanced by polyethylene glycol linkage of near infrared dyes conjugated to a chimeric anti-carcinoembryonic antigen antibody in a nude mouse model of human pancreatic cancer.
Maawy AA; Hiroshima Y; Zhang Y; Luiken GA; Hoffman RM; Bouvet M
J Biomed Opt; 2014; 19(10):101504. PubMed ID: 24887695
[TBL] [Abstract][Full Text] [Related]
17. A study on the antitumor effect of gemcitabine polybutylcy- anoacrylate nanoparticles coupled with Mucin 1 monoclonal antibody on pancreatic cancer
Zhang L; Zhu J; Hou Y; Li C; Liu H
J Cancer Res Ther; 2021 Dec; 17(7):1702-1708. PubMed ID: 35381742
[TBL] [Abstract][Full Text] [Related]
18. MUC1 expression in primary and metastatic pancreatic cancer cells for in vitro treatment by (213)Bi-C595 radioimmunoconjugate.
Qu CF; Li Y; Song YJ; Rizvi SM; Raja C; Zhang D; Samra J; Smith R; Perkins AC; Apostolidis C; Allen BJ
Br J Cancer; 2004 Dec; 91(12):2086-93. PubMed ID: 15599383
[TBL] [Abstract][Full Text] [Related]
19. Tumor-specific near-infrared nanobody probe rapidly labels tumors in an orthotopic mouse model of pancreatic cancer.
Lwin TM; Hernot S; Hollandsworth H; Amirfakhri S; Filemoni F; Debie P; Hoffman RM; Bouvet M
Surgery; 2020 Jul; 168(1):85-91. PubMed ID: 32370916
[TBL] [Abstract][Full Text] [Related]
20. A Mucin1 C-terminal Subunit-directed Monoclonal Antibody Targets Overexpressed Mucin1 in Breast Cancer.
Wu G; Kim D; Kim JN; Park S; Maharjan S; Koh H; Moon K; Lee Y; Kwon HJ
Theranostics; 2018; 8(1):78-91. PubMed ID: 29290794
[No Abstract] [Full Text] [Related]
[Next] [New Search]
